Form 10-K Iterum Therapeutics plc For: Dec 31
Tweet
Share
E-mail
http://archive.fast-edgar.com/20210312/ANBIS22CZC22UTB2222T2ZZ2STWDZY22R232
Filed on: March 12, 2021
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ABL Diagnostics Confirms Its Change of Scale in the First Half of 2026: Revenue up 90.0%, EBITDA Multiplied by More Than Four and Net Income up 343.3% Compared to the First Half of 2025
- TrueBridge Capital Partners Announces Close of Second Venture Secondaries Fund
- AFT Pharmaceuticals partners with Mark Cuban Cost Plus Marketplace to bring the new non-opioid pain medication, Combogesic® to the U.S.
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
